AVENUE SOLUTIONS

Lobbying for MODERNA, INC. · Biotechnology company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Health Issues

Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's delay in reviewing Moderna's flu vaccine

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.